FDA NEWS

PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA - MSN MoneyCentral
Panel Votes, 16-0, in Favor of Short-Term Treatment of Chronic Idiopathic Thrombocytopenic Purpura (ITP) CHICAGO, May 30 /PRNewswire-USNewswire/ -- GlaxoSmithKline GSK today announced that the United States Food and Drug Administration's Oncology
Source: news.moneycentral.msn.com

FDA panel favors Glaxo, Ligand blood drug - Forbes
Advisers to the Food and Drug Administration said Friday a blood-clotting drug from GlaxoSmithKline PLC and Ligand Pharmaceuticals Inc. is effective for short-term use, despite reservations by FDA scientists. A panel of 16 outside advisers voted
Source: www.forbes.com

UPDATE 2-FDA panel says data backs use of Glaxo's Promacta - Reuters
CHICAGO, May 30 (Reuters) - An expert advisory panel to the U.S. Food and Drug Administration said on Friday that current clinical data supports short-term use of GlaxoSmithKline Plc's (GSK.L: Quote , Profile , Research )(GSK.N: Quote , Profile
Source: www.reuters.com

Wyeth gets fast track designation from FDA for investigational vaccine - Forbes
NEW YORK (Thomson Financial) - Wyeth's pharmaceutical unit Thursday said it received fast track designation from the Food and Drug Administration for its investigational 13-valent pneumococcal conjugate vaccine for infants and toddlers. The company
Source: www.forbes.com

Tainted Drug Imports Set Off Warnings, Not FDA Action (Update2) - Bloomberg
May 30 (Bloomberg) -- Two Americans died and 15 suffered seizures. The suspected cause: The epilepsy medicine they depended on stopped working because of a counterfeit ingredient from overseas. The case of the flawed drug, made by a company that no
Source: www.bloomberg.com

FDA reminds asthma patients it's time to switch to CFC-free inhalers - Minneapolis Star Tribune
thanks to the HFA switchover, I discovered Advair and have all but eliminated my need for a fast acting inhaler, leading to a much more … read more active and fulfilling life. the kicker is the Advair costs about as much as my HFA inhaler would
Source: www.startribune.com

FDA: Time for asthma patients to switch inhalers - FOX News
WASHINGTON — Old-fashioned asthma inhalers that contain environment-harming chemicals will no longer be sold at year's end _ and the government is urging patients not to wait until the last minute to switch to newer alternatives. Patients use
Source: www.foxnews.com

FDA: Time for asthma patients to get new inhalers - MSN MoneyCentral
Sepracor Inc ( SEPR ) Stock Quote , Chart , News , Add to Watchlist WASHINGTON (AP) - Old-fashioned asthma inhalers that contain environment-harming chemicals will quit selling at year's end — and the government is urging patients not to wait until
Source: moneycentral.msn.com

FDA panel says data backs use of Glaxo's Promacta - Forbes
CHICAGO (Reuters) - An expert advisory panel to the U.S. Food and Drug Administration said Friday that current clinical data supports short-term use of GlaxoSmithKline (nyse: GSK - news - people ) Plc's experimental platelet-boosting drug, Promacta
Source: www.forbes.com